RxDoctor Payments DataLook up a doctor →

Darrell Herrington, DO

Family Medicine · San Angelo, TXNPI 1154388767

Payments from drug & device makers

$7,953,411in general payments, 2019–2025

Across 2,173 payments — averaging $3660.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$4.8M
  • Emergent Biosolutions Inc.$1.2M
  • Pfizer$623K
  • Astrazeneca UK Limited$353K
  • Lucira Health, Inc.$341K
  • Seqirus USA Inc$171K
  • plus $478K from 47 others
$26,504in research payments, 2019–2025

Across 10 payments — averaging $2650.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$24K
  • Novavax Inc$2K
  • BD$540

What the payments were for

  • Travel & lodging$1602%
  • Food & beverage$7,06798%
  • Gifts$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,953,411 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$146,295
Medicare patients
348
Services billed
6,060

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide177$209,750
Tresiba Flextouch U-200Insulin Degludec46$67,473
EliquisApixaban60$66,246
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog38$65,055
RexultiBrexpiprazole27$53,423
RybelsusSemaglutide35$48,292
JardianceEmpagliflozin34$39,599
TrulicityDulaglutide21$29,113
VraylarCariprazine Hcl11$26,261
MyrbetriqMirabegron36$22,314
XareltoRivaroxaban14$20,977
LinzessLinaclotide14$17,761
QuliptaAtogepant14$16,437
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$16,267
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$14,428

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,363$258,042212 claims
PfizerEliquis$623,088$66,24660 claims
AbbVieVraylar, Linzess, Qulipta, Synthroid$1,493$64,958117 claims
Otsuka America Pharmaceutical, Inc.Rexulti$145$53,42327 claims
Boehringer IngelheimJardiance$245$39,59934 claims
Lilly USA, LLCTrulicity$324$29,11321 claims
Johnson & JohnsonXarelto$88$20,97714 claims
AstraZenecaBreztri Aerosphere, Symbicort$9,771$18,59131 claims
GSKTrelegy Ellipta$13,090$16,26720 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$155$5,66615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in San Angelo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →